Lewis Silverman, the new director of pediatric hematology, oncology, and stem cell transplantation, is working to minimize the aftereffects of treatment to ensure the highest quality cure possible.
Columbia researcher Jasmine McDonald, who studies factors that affect the risk of developing breast cancer, discusses what is known about breastfeeding's protective influence on maternal health.
Columbia dermatologist Larisa Geskin discusses the potential dangers of the anti-sunscreen movement and how to protect yourself against the sun's harsh UV rays.
Researchers have found why cancer cells in oxygen-depleted environments are forced to rely on fat imports, a finding that could lead to new ways to understand and slow down tumor growth.
The program brings together physicians and nurse practitioners from multiple disciplines to provide care for smokers and ex-smokers who are at high risk for lung cancer and other complications.
Columbia geneticist Wendy Chung reflects on the progress made in cancer genetics and discusses the next frontier of using genetic information to design personalized cancer prevention strategies.
Columbia cancer researchers estimate that 60% of patients in a phase 2 clinical trial will have no sign of their cancer two years after treatment with combination therapy.
Heavy ions could radically improve radiation therapy for cancer treatment, but research is needed to understand how they work. With the aid of a new instrument at Columbia, scientists aim to find out.
Columbia's Lisa A. Kachnic, MD, a pioneer in radiation oncology, discusses the advancements made in the field of radiotherapy and the innovation to come.